Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Research & Development (2016 - 2025)

Cavitation Technologies' Research & Development history spans 16 years, with the latest figure at $4000.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 75.0% year-over-year to $4000.0; the TTM value through Dec 2025 reached $82000.0, up 67.35%, while the annual FY2025 figure was $95000.0, 55.74% up from the prior year.
  • Research & Development for Q4 2025 was $4000.0 at Cavitation Technologies, down from $7000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $42000.0 in Q1 2025 and bottomed at $1000.0 in Q2 2022.
  • The 5-year median for Research & Development is $9500.0 (2021), against an average of $14071.4.
  • The largest annual shift saw Research & Development crashed 90.0% in 2022 before it skyrocketed 433.33% in 2024.
  • A 5-year view of Research & Development shows it stood at $2000.0 in 2021, then crashed by 50.0% to $1000.0 in 2022, then surged by 3500.0% to $36000.0 in 2023, then plummeted by 55.56% to $16000.0 in 2024, then crashed by 75.0% to $4000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Research & Development are $4000.0 (Q4 2025), $7000.0 (Q3 2025), and $29000.0 (Q2 2025).